Stage-dependent deep gray matter alterations in cerebral small vessel disease revealed by 7 T quantitative susceptibility mapping
Journal of Cerebral Blood Flow & Metabolism · 20.07.2026
DOI: 10.1177/0271678x261473382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cerebral Blood Flow & Metabolism, online erschienen am 20.07.2026. Verfasst von Yue Yuan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: national natural science foundation of china, national key research and development program of china, Noncommunicable Chronic Diseases–National Science and Technology Major Project.
Abstract (Originalsprache)
Susceptibility alterations in deep gray matter (DGM) across clinical stages of cerebral small vessel disease (CSVD) remain unclear. In this case–control study, we used 7-Tesla magnetic resonance imaging quantitative susceptibility mapping (QSM) with source separation (APART–QSM) to characterize stage-related changes in normal controls, preclinical CSVD, and symptomatic CSVD. Compared with controls, CSVD showed increased QSM in the basal ganglia, particularly the putamen and globus pallidus, whereas small-magnitude QSM reductions were observed in selected thalamic and amygdalar subregions (all p < 0.05). Source separation revealed that basal ganglia abnormalities were mainly associated with increased paramagnetic components, whereas some thalamic alterations may involve increased diamagnetic components, suggesting distinct susceptibility contributions. Lower MoCA scores were associated with higher QSM and paramagnetic values in the globus pallidus, as well as higher diamagnetic values across the thalamus, putamen, and nucleus accumbens (all p < 0.05). Notably, right anterior globus pallidus QSM discriminated symptomatic CSVD from controls with the highest accuracy (AUC = 0.818). These findings reveal DGM susceptibility patterns associated with cognitive impairment, suggesting that 7 T QSM and susceptibility source separation may provide complementary information for early CSVD characterization and future longitudinal evaluation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
- GE HealthCare MR Research, Beijing, China.
- IRCCS Fondazione Stella Maris, Pisa, Italy.
- Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Yue Yuan, Shuai Jiang, Youjie Wang, Mangmang Xu, Bo Wu
Förderung
- national natural science foundation of china
- national key research and development program of china
- Noncommunicable Chronic Diseases–National Science and Technology Major Project
- Science and Technology Projects of Xizang Autonomous Region
- Sichuan Science and Technology Program
- west china hospital, sichuan university
- Italian Ministry of Health
Zitieren
APA
Yuan, Y., Jiang, S., Wang, Y., Liang, H., Lancione, M., Tosetti, M., Xu, B., Yan, Y., Xu, M., Li, S., Zeng, J., Tang, L., Peng, P., Lui, S., Sun, J., & Wu, B. (2026). Stage-dependent deep gray matter alterations in cerebral small vessel disease revealed by 7 T quantitative susceptibility mapping. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1177/0271678x261473382
Vancouver
Yuan Y, Jiang S, Wang Y, Liang H, Lancione M, Tosetti M, et al. Stage-dependent deep gray matter alterations in cerebral small vessel disease revealed by 7 T quantitative susceptibility mapping. Journal of Cerebral Blood Flow & Metabolism. 2026. doi:10.1177/0271678x261473382
BibTeX
@article{Yuan2026,
author = {Yuan, Yue and Jiang, Shuai and Wang, Youjie and Liang, Huilou and Lancione, Marta and Tosetti, Michela and Xu, Boyan and Yan, Yuying and Xu, Mangmang and Li, Siyi and Zeng, Jiaxin and Tang, Lu and Peng, Pengfei and Lui, Su and Sun, Jiayu and Wu, Bo},
title = {Stage-dependent deep gray matter alterations in cerebral small vessel disease revealed by 7 T quantitative susceptibility mapping},
journal = {Journal of Cerebral Blood Flow & Metabolism},
year = {2026},
doi = {10.1177/0271678x261473382}
}
EUVIMED